van Dijk E, van Werkhoven E, Asher R, Mooi JK, et al. Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer; a post-hoc analysis of the randomized phase III-trial AGITG-MAX. Int J Cancer 2022 Apr 30. doi: 10.1002/ijc.34061.
PMID: 35489024